ES2032390T3 - Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe). - Google Patents

Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).

Info

Publication number
ES2032390T3
ES2032390T3 ES87100931T ES87100931T ES2032390T3 ES 2032390 T3 ES2032390 T3 ES 2032390T3 ES 87100931 T ES87100931 T ES 87100931T ES 87100931 T ES87100931 T ES 87100931T ES 2032390 T3 ES2032390 T3 ES 2032390T3
Authority
ES
Spain
Prior art keywords
topical use
cpe
reservation
art
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87100931T
Other languages
English (en)
Spanish (es)
Inventor
Yujiro Yamamoto
Takahiro Ogawa
Yoshikazu Kuribayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2032390T3 publication Critical patent/ES2032390T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES87100931T 1986-01-31 1987-01-23 Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe). Expired - Lifetime ES2032390T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61020361A JPH0696521B2 (ja) 1986-01-31 1986-01-31 眼局所投与用眼圧降下剤

Publications (1)

Publication Number Publication Date
ES2032390T3 true ES2032390T3 (es) 1996-07-16

Family

ID=12024951

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87100931T Expired - Lifetime ES2032390T3 (es) 1986-01-31 1987-01-23 Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).

Country Status (9)

Country Link
US (1) US4826879A (US07498051-20090303-C00003.png)
EP (1) EP0235544B1 (US07498051-20090303-C00003.png)
JP (1) JPH0696521B2 (US07498051-20090303-C00003.png)
AU (1) AU591228B2 (US07498051-20090303-C00003.png)
CA (1) CA1282704C (US07498051-20090303-C00003.png)
DE (1) DE3777858D1 (US07498051-20090303-C00003.png)
ES (1) ES2032390T3 (US07498051-20090303-C00003.png)
GR (1) GR3004513T3 (US07498051-20090303-C00003.png)
HU (1) HU199285B (US07498051-20090303-C00003.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306731A (en) * 1985-06-14 1994-04-26 Massachusetts Eye And Ear Infirmary Method and products for treating the eye
US5863948A (en) * 1985-06-14 1999-01-26 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5314916A (en) * 1993-04-19 1994-05-24 Alcon Laboratories, Inc. B2 adrenegic agonists and use thereof in the treatment of glaucoma
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US7678836B2 (en) * 1999-11-04 2010-03-16 Fxs Ventures, Llc Method for rendering a contact lens wettable
US8557868B2 (en) * 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
US20070098813A1 (en) * 2000-11-08 2007-05-03 Fxs Ventures, Llc Ophthalmic and contact lens solutions with a peroxide source and a preservative
AU2720602A (en) * 2000-11-08 2002-05-21 Bio Concept Lab Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US9308264B2 (en) 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
US20070110782A1 (en) * 2000-11-08 2007-05-17 Fxs Ventures, Llc L-histidine in ophthalmic solutions
US20060127496A1 (en) * 2000-11-08 2006-06-15 Bioconcept Laboratories L-histidine in ophthalmic solutions
US20060148665A1 (en) * 2000-11-08 2006-07-06 Bioconcept Laboratories Ophthalmic and contact lens solutions containing forms of vitamin b
US9492582B2 (en) * 2000-11-08 2016-11-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN106075449A (zh) * 2005-07-14 2016-11-09 尼奥塞蒂克斯公司 用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
JP2010506941A (ja) * 2006-10-17 2010-03-04 リセラ，インク． 甲状腺眼症の治療のための方法、組成物及び製剤
US9132084B2 (en) * 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
KR101638301B1 (ko) * 2010-01-15 2016-07-08 네오쎄틱스 인코포레이티드 동결건조 케이크 제제
CN105832681A (zh) 2010-11-24 2016-08-10 纽赛蒂克斯公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
CN103664816B (zh) * 2011-01-06 2016-03-02 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826332B2 (ja) * 1974-04-25 1983-06-02 武田薬品工業株式会社 テトラロ−ルカゴウブツ ノ セイゾウホウ
JPS5833219B2 (ja) * 1974-06-12 1983-07-18 武田薬品工業株式会社 テトラロ−ルカゴウブツノ セイゾウホウ
DK254975A (da) * 1974-06-12 1975-12-13 Takeda Chemical Industries Ltd Fremgangsmade til fremstilling af aminotetralolforbindelser
JPS5283826A (en) * 1976-01-01 1977-07-13 Takeda Chem Ind Ltd Tetralol compound
US4402976A (en) * 1981-04-24 1983-09-06 E. R. Squibb & Sons, Inc. Method for treating glaucoma with systemic nadolol compositions
JPS5970653A (ja) * 1982-10-15 1984-04-21 Takeda Chem Ind Ltd 眼圧低下剤
IT1163107B (it) * 1983-02-15 1987-04-08 Simes Composizioni farmaceutiche e loro uso nel trattamento del glaucoma

Also Published As

Publication number Publication date
EP0235544A3 (en) 1989-11-29
JPH0696521B2 (ja) 1994-11-30
AU591228B2 (en) 1989-11-30
US4826879A (en) 1989-05-02
EP0235544A2 (en) 1987-09-09
EP0235544B1 (en) 1992-04-01
JPS62178514A (ja) 1987-08-05
HU199285B (en) 1990-02-28
CA1282704C (en) 1991-04-09
HUT46210A (en) 1988-10-28
AU6813987A (en) 1987-08-06
DE3777858D1 (de) 1992-05-07
GR3004513T3 (US07498051-20090303-C00003.png) 1993-04-28

Similar Documents

Publication Publication Date Title
ES2032390T3 (es) Composicion antihipertensiva ocular para uso topico. (reserva del art. 167.2 cpe).
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
DE3066859D1 (en) Autoclavable emulsions
FI891592A0 (fi) Hudvaordskomposition och foerfarande foer dess framstaellning.
MX9405006A (es) Solucion oftalmica para lagrimas artificiales.
ES2086270T5 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
KR940006575A (ko) 증가된 안내압 치료를 위한 안구 국소 투여용 약제학적 조성물
KR910000111A (ko) 치아 구조의 광물질 소실된 부분을 광물질 분재보급 시키기 위한 방법
PA8401801A1 (es) Agentes bloqueadores neuromusculares
DE1617320B2 (de) Hautbehandlungsmittel
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ES2165855T3 (es) Agente de normalizacion de la coagulacion sanguinea que contiene tcf-ii como ingrediente activo.
BR0017340A (pt) Tratamento de trauma e outras indicações
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
MX9301627A (es) Agente para utilizarse como un antiirritante y composicion que lo contiene.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ES528280A0 (es) Procedimiento para la preparacion de emulsiones acuosas para el suavizado de material de fibra.
ES455721A1 (es) Procedimiento para la preparacion de una nueva sal de pipe- raziniluracilo.
MX9302818A (es) Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina.
US3431340A (en) Medicinal preparation for the treatment of burns and other traumatic wounds
KR930702015A (ko) 각막 장해 치료제
ES2073245T3 (es) Agentes para el tratamiento de la cornea.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 235544

Country of ref document: ES

FG2A Definitive protection

Ref document number: 0235544

Country of ref document: ES